Effects of the Menstrual Cycle on Triceps Surae Properties in Women
NCT ID: NCT06214442
Last Updated: 2024-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2023-11-10
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea
NCT07239232
Effect of Kinesio Taping in Women With Knee Osteoarthritis
NCT03624075
Knee Pressure Stimuli on Quadriceps Strength in Knee Osteoarthritis
NCT05826236
Lateral Wedge Insole With Subtalar Strapping for Knee Osteoarthritis
NCT01739296
The Effect on Knee Joint Loads of Analgesic Use Compared With Exercise in Patients With Knee Osteoarthritis - An RCT
NCT01638962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physically active eumenorrheic women with regular menstrual cycle
Women who practice physical exercise and have regular menstruation ranging from 25 to 38 days.
Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle
Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.
Sedentary eumenorrheic women with regular menstrual cycle
Women who do not practice physical exercise and have regular menstruation ranging from 25 to 38 days.
Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle
Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.
Physically active women using hormonal contraceptives
Physically active women using oral hormonal contraception combined with estrogen and progesterone within the last six months.
Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle
Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.
Sedentary women who use hormonal contraception
Sedentary women using oral hormonal contraception combined with estrogen and progesterone within the last six months.
Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle
Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluations of the mechanical properties of the achilles tendon in different phases of the menstrual cycle
Monitoring assessments to verify the effect of different phases of the menstrual cycle on the neuromechanical properties of the Achilles tendon.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index between 20 and 25 kg/m2.
* Normal ankle function and range of motion.
* Do not use hormonal contraception of any kind or supplements hormones for at least the 6 months prior to the study.
* No complaints of pain or history of lower limb injury.
* For the physically active group, practice regular physical exercise at least 3 times a week for the past 6 months.
* For the sedentary group, not practicing regular physical exercise in the last 6 months.
* Body Mass Index between 20 and 25 kg/m2.
* Normal ankle function and range of motion.
* Make use of any method of oral hormonal contraception (compressed).
* Make use of combined oral hormonal contraception with estrogen and progesterone (ethinylestradiol + Drospirenone) for at least 6 months before participating in the study.
* Do not use other hormone supplements for at least 6 months prior to the study.
* No complaints of pain or presence of pathologies in the lower limb
* For the physically active group, practice regular physical exercise at least 3 times a week for the past 6 months.
* For the sedentary group, not practicing regular physical exercise in the last 6 months
Exclusion Criteria
* Women who have anovulatory cycles or phase lutea deficiency.
* Women in early menopause.
* Pregnant or lactating women.
* Women with oligomenorrhea (menstrual cycles longer than 35 days, or delay of menstruation for the same period).
* Women with hypothalamic amenorrhea.
* Female smokers.
* Women with metabolic syndrome.
* For women using hormonal contraceptives, women who use adhesive, injectable, intrauterine devices, implants, vaginal rings, as well as progesterone-only CH methods.
18 Years
30 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marco Aurélio Vaz, PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marco Aurélio Vaz, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Vaz
Role: STUDY_CHAIR
Federal University of Rio Grande do Sul
Marco Vaz
Role: STUDY_DIRECTOR
Federal University of Rio Grande do Sul
Marco Vaz
Role: PRINCIPAL_INVESTIGATOR
Federal University of Rio Grande do Sul
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marco Aurelio Vaz
Porto Alegre, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Marco VAZ
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5.989.983
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.